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Abstract 
We describe the events surrounding the identification of the exosome complex and the 
subsequent early development of the field. Like many scientific discoveries, the initial 
identification and characterization of the exosome was a based on a combination of skill, 
good fortune - and the availability of cutting edge technology. 
 
 
Introduction 
The early 1990s were in some respects a frustrating time for ribosome research. On the one 
hand, established plasmid-based rDNA systems enabled the precise mapping and 
mutagenesis analysis of processing sites within the pre-rRNA sequence, and a steady flow 
of processing factors were being identified by genetic, biochemical and bioinformatic 
approaches. However, genetic depletion of the identified trans-acting factors typically 
caused a common set of defects in pre-rRNA processing that led to a general loss of rRNA 
levels, and it was therefore impossible to identify the specific molecular function of the 
protein. We therefore decided to concentrate on trying to identify enzymes that participate in 
the pre-rRNA processing reactions. The identification of these factors promised opportunities 
for more insightful experiments such as in vitro biochemical analyses, targeted mutagenesis 
studies and studies on the regulation of the pathway. 
 
From northerns to nucleases 
We were therefore interested in screening banks of conditional yeast mutants for those 
showing blocks in specific steps in the pre-rRNA processing pathway, rather than just the 
loss of the pre-rRNAs. The problem was that generating and testing banks of mutants 
required, and still requires, a great deal of work. Happily, at about this time Zoe Lygerou, in 
the group of Bertrand Séraphin also working at EMBL, was attempting to identify mutants 
defective in the interaction between the U4 and U6 small nuclear RNAs. To this end they 
had generated a collection of around 250 temperature-sensitive (ts) lethal yeast strains, 
extracted RNA from each and resolved the RNA on non-denaturing gels suitable for 
separating low molecular weight RNAs. The gels were far from ideal for the analysis of pre-
rRNA processing defects and carried RNA from only around 250 strains, not all of which had 
given usable separation (see Figure 1). The blots were, however, to hand and so we 
screened them by northern hybridization for defects in processing of the similarly sized 5.8S 
rRNA. 
 
A small number of the ts mutants showed apparent alterations in 5.8S rRNA levels and/or 
accumulation of potential precursors and for two of these, reanalysis of the mutant by RNA 
extraction and separation on denaturing gels confirmed the suggested phenotype. The first 
mutant to be characterized was found to be defective in 5' maturation of both pre-tRNA and 
5.8S rRNA. The corresponding gene was cloned by complementation of the ts growth 
phenotype. Subsequent analysis revealed that it encoded a protein that was a common 
component of the endoribonucleases RNase P and RNase MRP, the first such protein to be 
identified 1. RNase P cleaves the 5' end of tRNAs (reviewed in 2), whereas RNase MRP 
cleaves the pre-rRNA at site A3 both in vivo and in vitro 1, 3, 4. The protein is essential, 
conserved to humans and was designated Pop1 (for processing of precursor RNAs). This 
finding led us to propose that RNase MRP and RNase P have evolved from a common 
enzyme involved in ribosome synthesis 5. 
 
Encouraged by these results, we then turned our attention to the second ts mutation. In this 
case, better characterization of the pre-rRNA processing phenotype revealed a ladder of 3’-
extended forms of the 5.8S rRNA. The corresponding gene was cloned and designated as 
RRP4 (rRNA processing defective); like Pop1, the Rrp4 protein was found to be essential 
and well conserved to humans. By expressing an epitope-tagged form of Rrp4 in yeast and 
purifying the protein from cell lysates, we showed that Rrp4 had an associated 3’ to 5’ 
exoribonuclease activity. These observations led us to propose that the 3’ end of the mature 
5.8S rRNA is generated by a 3' to 5' exonuclease acting from the downstream C2 cleavage 
site 6. 
 
A glimpse of the exosome 
Glycerol gradient ultracentrifugation analyses indicated that Rrp4 is a component of a 
moderately sized complex with an estimated mass of approximately 300-400kDa. To identify 
other protein components of this complex, the epitope-tagged Rrp4 was affinity purified from 
peak gradient fractions. These studies predated the establishment of the TAP tagging 
procedure 7 and the purifications were performed using a noncleavable protein A tag (see 
Figure 2). After binding to IgG beads, retained proteins were nonspecifically eluted with 
acetic acid and resolved by SDS-PAGE. A significant problem with early analyses was the 
predominance of IgG molecules on the protein gels due to acid leaching from the beads. 
This problem was partially minimized by using gel loading buffers lacking mercaptoethanol. 
At this time, the identification of proteins from excised gel bands was far from routine but, 
fortunately, Mathias Mann was then developing this approach and agreed to analyze the 
samples. Despite the large amount of IgG present in the samples, Andrej Schevchenko in 
Matthias Mann’s lab identified four other proteins from the first gels, along with Rrp4. For 
consistency, we designated these proteins Rrp41, Rrp42, Rrp43, and Rrp44. The band 
containing Rrp41 was much stronger than expected in the initial gels, but 6 peptides 
sequenced by mass spectrometry (a lot for that time) all corresponded to Rrp41, leading us 
to conclude (incorrectly as it turned out) that it was present in multiple copies in the complex 
8. Subsequent analyses were to reveal the presence of multiple, similarly sized proteins in 
the complex. Reassuringly, genetic depletion of each of the identified proteins elicited the 
same 5.8S rRNA processing phenotype observed in the original rrp4-1 ts mutant. To our 
delight, one of the proteins identified, Rrp44, was clearly homologous to bacterial RNase R, 
a member of the RNase II family of processive, hydrolytic exonucleases. We obtained a 
recombinant expression construct for Rrp44 from the lab of Takeharu Nishimoto, who had 
previously identified the S.pombe homologue of Rrp44 (Dis3) through interactions with the 
Ran GTPase. Using this, we were able to show that Rrp44 had the predicted processive, 
exoribonuclease activity. We now had a candidate enzyme for the observed 5.8S rRNA 
processing activity. 
 
However, we noted that the processive activity of recombinant Rrp44 did not correlate with 
the distributive activity that was associated with Rrp4 pull-downs from yeast cell extracts, 
suggesting that either the activity of Rrp44 was altered upon assembly into the complex or 
that at least one other component of the complex also has catalytic activity. Both 
explanations eventually turned out to be correct. Before analyzing the Rrp4 complex, we had 
expressed Rrp4 in E. coli and tested the recombinant protein for exonuclease activity. We 
observed a distributive activity very similar to that seen with the affinity purified yeast 
complex, which convinced us that Rrp4 was a distributive exonuclease. This result proved to 
be irreproducible and presumably reflected the presence of a contaminant activity. Studies 
by Andrej Dziembowski and Bertrand Séraphin 9 later showed that the distributive in vitro 
activity of the exosome was probably actually due to Rrp6, which was subsequently 
identified as a component of the complex. 
 
The complete complex 
Bioinformatics analyses also played an important part in the characterization of the exosome 
complex. Initial BLAST analyses revealed that Rrp41 was homologous to another E. coli 
nuclease, RNase PH. BLAST searches failed to identify homologues for Rrp42 and Rrp43, 
but Sara Mian identified a family of yeast proteins related to RNase PH including Rrp41, 
Rrp42 and Rrp43 8, 10. This family was also predicted to include the uncharacterized products 
of the YDR280w and YGR095c genes. Around this time Roy Parker and Reed Wickner 
discovered that Rrp41 was identical to the product of the previously identified but uncloned 
SKI6 gene, which the Parker lab then showed to function cytoplasmic mRNA turnover 11, 12. 
They also realized that yet another yeast protein, Mtr3, was homologous Rrp41/Ski6 and 
RNase PH.   
 
Based on this sequence homology, Christine Allmang made conditional mutants of the two 
uncharacterized genes and showed that depletion of the encoded proteins also led to the 
accumulation of 3' extended forms of 5.8S rRNA 13. We named these genes RRP45 and 
RRP46, respectively. Analysis of the mtr3-1 ts mutant, obtained from the lab of Alan 
Tartakoff, revealed a similar defect in 5.8S rRNA maturation. Exosome complexes from 
Archeae and plants exhibit exonuclease activity mediated by RNase PH related subunits 14-
16, but this does not appear to be the case for other eukaryotic systems tested. 
 
In the meantime, we had made two further modifications to the exosome purification 
procedures. Firstly, we resolved the cell lysates by ion exchange chromatography prior to 
SDS-PAGE analysis. This enabled a significant scale-up of the experiments and provided a 
purification step that was considerably more rapid and as equally effective as resolving 
lysates through glycerol gradients. We subsequently adopted the technique, developed by 
Dirk Görlich, for eluting proteins retained on IgG beads with a gradient of increasing MgCl2 
concentration 17. Together, these two approaches produced gels that allowed the 
identification of Rrp45, Rrp46, Mtr3 and two newly identified proteins, Rrp40 and Csl4, in 
addition to Rrp4 and Rrp41-44. Genetic depletion of Rrp40 and Csl4 also led to the same 
5.8S rRNA processing phenotype. The gels of the gradient eluate fractions also revealed 
that Rrp44 was not as stably bound to the complex as the other identified components, 
demonstrating the existence of a stable nonomeric “core”. We were also able to 
biochemically resolve two distinct forms of the complex that differed by the presence or 
absence of the nuclear protein Rrp6, another exoribonuclease that had been shown to 
function in 5.8S rRNA processing by the group of Scott Butler 18. Subsequently, we and 
others identified three additional substoichiometric components of the complex, the 
cytoplasmic GTPase Ski7 and the nuclear RNA binding proteins Rrp47/Lrp1 and Mpp6 19-24.  
 
A broader perspective 
We generated cDNA expression constructs of the gene encoding the human homologue of 
Rrp4 from a HeLa cDNA library that was provided by Karsten Weis, who was then in the lab 
of Angus Lamond at EMBL, and were able to show that overexpression of the encoded 
protein complemented the ts growth phenotype of the rrp4-1 mutant. Coimmunoprecipitation 
studies subsequently showed that a complex closely related to the yeast exosome was 
present in human cells, where it had initially been identified as the PM-Scl complex, a target 
of autoimmune antibodies in patients suffering from the unfortunate sounding polymyositis-
scleroderma overlap syndrome (PM-Scl - now termed Scleromyositis) 13, 25. The human 
exosome complex was then purified by expressing epitope-tagged hRrp4 and shown to act 
in ARE-mediated mRNA decay 26. 
 
The barrel shape of the exosome was first predicted by Ambro van Hoof and Roy Parker 27, 
who insightfully suggested that the structure might be analogous to the proteasome. Support 
for this model was provided by structural analysis of the Bacterial PNPase, which was 
shown to have a domain composition strikingly similar to that of the exosome 28, 29. Finally, 
the crystal structures of the archaeal and then the human exosome confirmed the exosome 
structure as a barrel with a central cavity through which substrates pass 16, 30-32. 
 
The distributive activity of yeast exosome complexes observed in vitro did not correlate well 
with genetic and biochemical data that indicated potent activity in vivo on highly structured 
RNA-protein complexes. The obvious hypothesis was that the exosome was largely 
dependent upon additional cofactors for substrate identification and activation in vivo, and 
numerous cofactors have since been identified; reviewed in 33. Recent studies have also 
revealed an endoribonuclease activity of Rrp44 34-36.  
 
Although the exosome was initially characterized as a pre-rRNA processing complex, it was 
immediately clear from the growth characteristics of the ts rrp4-1 mutant that it had 
additional functions that are essential for normal cell growth. In addition to the studies linking 
the exosome to cytoplasmic mRNA turnover 12, work in our lab and others soon revealed 
functions in the processing of small stable RNAs 37 and subsequently showed it to function in 
surveillance pathways that eliminate aberrantly processed or assembled transcripts 38-41. 
Loss of these functions would nevertheless not be expected to trigger the rapid growth 
inhibition that can be seen in conditional exosome mutants. This may now have been largely 
explained by recent analyses of the plethora of cryptic noncoding RNAs; see for example 42 
and reviews by 33, 43. These have revealed a fundamental function of the exosome and its 
cofactors as key gatekeepers of the transcriptome. 
 
Conclusion 
Despite many publications, the identification of a vast number of substrates and the 
characterization of numerous cofactors, key question concerning the exosome remain 
unanswered. In particular, how are the distinct catalytic activities of the complex coordinated 
and how do the cofactors modulate the activity of the exosome complex at the molecular 
level? Resolving these questions will require a range of approaches - and should continue to 
provide a fruitful field of study for some time to come. 
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Figure Legends: 
 
Figure 1: Identification of strain At187 harboring the rrp4-1 mutation. 
A: RNA was extracted under non-denaturing conditions from a collection of temperature-
sensitive mutant yeast strains, separated by native gel electrophoresis and analyzed by 
northern hybridization. Due to the native gel conditions 5.8S rRNA largely remains 
associated with the 25S rRNA, but the ITS2 probe in strain At187 lit bands above the 5.8S 
rRNA. B: Subsequent analyses on denaturing gels revealed that these represented the 
accumulation of 3’ extended species. A sequencing ladder was run on the same gel and 
transferred to the northern filter as a size marker. Following back-crossing, the RRP4 gene 
was cloned by complementation of the ts-phenotype of the rrp4-1 mutation that is carried by 
this strain. 
 
Figure 2: First analysis of the exosome complex 
Analytical gel of the first exosome preparation that was purified over a glycerol gradient. 
Western analyses of the gradient fractions identified two peaks of Rrp4, which were then 
purified by affinity chromatography on IgG sepharose beads, eluted with acetic acid and the 
proteins resolved by SDS-PAGE. Lane 1, pooled gradient fractions from peak I. Lane 2, 
supernatant from peak I. Lane 3, acid eluate from peak I. Lane 4, 10-fold enriched eluate 
fraction. Lanes 5-8, equivalent samples from peak II. The sizes (kDa) of molecular weight 
markers are indicated. Protein bands in the peak II eluate fraction that were subsequently 
identified by mass spectrometry are labeled. 
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